# FDA 483 - Sanjay Ramteke, M.D. - May 23, 2025

Source: https://www.globalkeysolutions.net/records/483/sanjay-ramteke-md/65f50d7f-c028-4f23-bbf2-5c5ff29c1c4f

> FDA 483 for Sanjay Ramteke, M.D. on May 23, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sanjay Ramteke, M.D.
- Inspection Date: 2025-05-23
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: Sanjay Ramteke, M.D., a clinical investigator in Nagpur, India, was cited for failing to adhere to an investigational plan. Specifically, the firm did not discontinue an investigational product for a study subject who experienced neutropenia, a serious adverse event. This lapse resulted in the subject receiving another round of the study drug despite the adverse reaction.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/koffi-a-amegadje/817a228e-0003-43d0-bf59-71aeba0fd1f5)

Company: https://www.globalkeysolutions.net/companies/sanjay-ramteke-md/2e6168cd-a15f-4e94-a1c7-4a50d3d4501e

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8